Praziquantel (PZQ) (Biltricide, Droncit) is a broadly effective trematocide and cestocide; data on its chemistry, pharmacokinetics and therapeutic efficacy against parasites in hosts including man have been recently reviewed by Andrews et al. (1983) . PZQ is chemically unrelated to other antischistosomal drugs and possesses unique properties.
Praziquantel (PZQ) (Biltricide, Droncit) is a broadly effective trematocide and cestocide; data on its chemistry, pharmacokinetics and therapeutic efficacy against parasites in hosts including man have been recently reviewed by Andrews et al. (1983) . PZQ is chemically unrelated to other antischistosomal drugs and possesses unique properties.
PZQ has been shown to be effective against trematodes (e.g. Schistosoma, Paragonimus, Clonorchis, Opisthorchis, Metagonimus, Heterophyes) of man and animals independent of their location within the host body. Parasites living in the blood are almost equally susceptible to the drug as those in the intestine, lung or liver. All adult cestodes (e.g. Taenia, Hymenolepis, Diphyllobothriurn. Mesocestoides) and many larval cestodes can be successfully treated with PZQ; however, PZQ is not effective against nematodes. The reason is presumably the impervious cuticle of the nematodes, which is very different from the syncytial tegument of trematodes and cestodes which has absorptive functions.
The pharmacokinetics of PZQ have been extensively studied and reviewed by Andrews (1985) . After oral administration 80-100% of PZQ is absorbed. The invasion half-life varies from 0.1 to 0.3 h. In man, maximal serum concentrations of unchanged drug of 0.84.1 PM are reached 1-3 h after application of an oral dose of 2&50mg/kg, respectively. PZQ is subjected to a pronounced first-pass metabolism. In rats, up to 74% of the drug is metabolized within 5min. Only 26% remains unchanged and this fraction rapidly disappears. PZQ is very rapidly distributed throughout all organs, with the highest concentrations occurring in the liver and the kidneys. Peak concentrations of PZQ after oral administration of equally effective doses to mouse and man ( > 95% parasite reduction or > 95% egg reduction) are reached after 5 min and after 1-3 h, respectively. Elimination in rats, dogs, monkeys and sheep is mainly renal (6&8OO/, of the excreted portion), while 15-37% is found in the bile and 6% is excreted into the intestinal lumen. Within 32 h 70-90% of an orally administered dose has been cleared from the body. PZQ itself is the active molecule requiring no metabolic alteration in order to become effective. Metabolic transformations by the host always result in less active or inactive metabolites.
The therapeutic potency of PZQ can be increased by application of multiple oral doses at short intervals. The total amount of drug required to produce comparable parasite reduction in mice can be reduced by more than 70%: 10 doses of 18.5 mg/kg each every hour instead of one dose of 685 mg/kg. Thus the antischistosomal effect is not related to the absolute height of the maximal plasma concentrations, but rather to the length of exposure to the drug, i.e. PZQ follows a threshold/time model rather than a peak height model. Studies in vivo and in vitro indicate that the threshold concentration is somewhere between 0.32 and l . O p~, and this PZQ concentration is reached in man after application of curative drug doses.
Schistosoma mansoni takes up PZQ rapidly. The concentration inside the parasite equals that in the medium within 2 min and increases further with time. Drug uptake is reversible and not dependent on the Ca2+ concentration of the external medium. PZQ appears to be distributed equally throughout the parasite tissues and there is no formation of metabolites in the parasite.
Abbreviation used: PZQ, praziquantel
Two striking phenomena can be observed in schistosomes exposed to PZQ: an almost instantaneous spastic paralysis of the parasite musculature and a rapid structural damage of the syncytial tegument. Concentrations above 0.324.6 pM cause tetanic contractions within seconds, which can also be recorded as an immediate increase of the muscle tension (Fig. I ). The latter depends on the PZQ concentration with a maximum at I~M (Fig. 2) . Lower concentrations can increase parasite motility (Fig. 2) . Motility is maximal at 0.32 PM in the case of Schistosoma mansoni (Chavasse et al., 1979) , while a concentration as low as 0 . 0 1 6~~ is still stimulatory for Schistosoma japonicum (Xiao et al., 1980) . The threshold concentration of PZQ as derived from electrophysiological experiments lies in the range of 0.324.6 PM, which is consistent with the plasma concentrations measured in man after administration of a therapeutically effective dose of PZQ. The PZQ-induced contraction of schistosomes depends on the presence of Ca2+. Depletion of external Ca2+ or addition of an excess of Mg2+ abolishes drug-induced contractions (Pax et al., 1978) . Ca2+ influx into Schistosoma mansoni proceeds within 1 min in the presence of 1 PM-PZQ ( Fig. I ; Pax et al., 1978) . Time course studies reveal that the onset of tegumental damage, observed as surface blebbing, occurs -within 30s in the presence of 1 ~M -P Z Q ( Fig. I ; Becker et al., 1980; Mehlhorn et al., 1983; Bricker et al., 1983) . Thus the Ca2+ influx is as quick as the stimulation of muscle tension, contraction and tegumental alterations. All other PZQ-induced events are observed after minutes or hours: increase of Na+ uptake, inhibition of K + uptake ( Fig. I ; Pax et al., 1978) , depolarization of the parasite's tegument (Fetterer et al., 1980; Bricker et al., 1982) as well as influences of PZQ on metabolic processes (Fig. I) . However, it should be emphasized that the relative long periods of observation may be caused by the insensitivity of the methods used. It is likely that the PZQ-induced alterations of the metabolic processes also occur within minutes.
The existence of a threshold concentration for the action of PZQ can also be seen by observing so-called secondary effects: the activity of ATPase in Schistosoma mansoni is slightly reduced between 0.1 and ~. O~M -P Z Q and disproportionally more at IOPM (Fig. 2; Nechay et a/., 1980) . This effect has been explained by the perturbance of the tegumental environment of ATPase and not by direct inhibition. Furthermore, we find an inhibition of glucose uptake, decrease of lactate excretion and a maximal stimulation of glycogen breakdown above 0.1 PM-PZQ (Fig. 2) .
What is the molecular basis for the action of PZQ? Most inhibitors of known neurotransmitters of Schistosoma mansoni and other pharmacologically active agents d o not antagonize the action of PZQ, e.g. carbachol, spiroperidol, bromolysergic acid diethylamide, imipramine, dopamine, noradrenaline, 5-hydroxytryptamine, arecoline, metrifonate, pentobarbital, atropine, mecamylamine, pempidine and also the Ca2+-channel blocker D600, as reviewed by Andrews et al., (1983) . PZQ does not act as a Ca2+ ionophore (Pax et al., 1978) . However, one drug, namely fluoxetine, was found to attenuate the PZQ-induced Ca2+-influx as well as contracture (Pax et al., 1979) .
Fluoxetine is an amphiphilic cationic drug, as are chlorpromazine, imipramine, amitriptyline and propranolol. These drugs share some common properties with respect to membrane actions; the fluidize acidic phospholipid membranes and displace Cay+ from membranes (Seeman, 1972) . They inihibit membrane fusion, depolarization of excitable membranes (Poste & Allison, 1973) and the conductance of frog sciatic nerves (Seeman, 1972) .
The phospholipids of Schistosoma mansoni account for 
Fig. 2. Concentration-dependent pruziquantel-induced processes
Vol. 15 3 6 4 8 % of the total amount of lipids; however, the exact composition of the phospholipids in the tegumental surface membranes is not known. An indication of their composition may be derived from work done on the multilamellar bodies of the tegumental syncytium, which are thought to be incorporated into or on t o the surface of the parasites: at least 25% of the total phospholipids of these multilamellar bodies are acidic ones, mainly phosphatidylserine ( 1 So/,) and phosphatidylglycerol (So/,), but also phosphatidylinositol (So/,) and phosphatidic acid as received by Andrews (1985) . Interestingly 1 I-day-old schistosomes possess the highest rate of phospholipid metabolism, while the latter is very low in schistosomules and adult worms (Vial c/ d., 1985) . The parasite stages with reduced phospholipid turnover, however, are especially susceptible to P Z Q (Gonnert 8~ Andrews, 1977) . Therefore, it is tempting to speculate that PZQ might excert its mode of action by interaction with tegumental phospholipids.
To support this idea. we performed two series of experiments. In one series we examined the influence of the amphiphilic cationic drugs on the carbohydrate metabolism in Schistosoma mansoni, which requires intact membranes for optimal functioning, to see whether PZQ exerts comparable effects. In the other set of experiments, the interactions of the same drugs with different synthetic phospholipids were studied directly. Between 10 and 1 0 0~~ the amphiphilic cationic drugs stimulate glucose uptake and lactate excretion and inhibit both processes a t 1 mM. PZQ, on the other hand, stimulates a t 0.1 p~ and inhibits above 1 p~. Furthermore, PZQ a t 1 O p~ inhibits Na+-sensitive 5-hydroxytryptamine uptake and excretion from the worms, a n effect which is also observed a t IOp~-fluoxetine (Webb, 1985) . Glycogen breakdown is maximally stimulated by 1 PM-PZQ. A similarity between fluoxetine and PZQ can also be seen in their influence on the 5-hydroxytryptaminestimulated carbohydrate metabolism. When Schistosoma BIOCHEMICAL SOCl ETY TRANSACTIONS mansoniare preincubated with I O~M -P Z Q or 1 mM-fluoxetine further addition of 100 p~-5-hydroxytryptamine can no longer stimulate the carbohydrate metabolism. In the presence of 0.1 p~-P Z Q or 50 pwfluoxetine, S-hydroxytryptamine exerts its full stimulatory effect. Thus it appears that amphiphilic cationic drugs and PZQ influence the carbohydrate metabolism by interfering with the same binding sites in the schistosomal tegument.
With respect to alterations of membrane properties there are some important differences between PZQ, which is electrically neutral. and amphiphilic cationic drugs, which are positively charged. The latter are able to displace Ca'+ from membranes thus reducing membrane bound Ca'+ (Seeman, 1972) ; PZQ enhances the Ca'+ permeability (Pax et al., 1979 . Fluoxetine increases the fluidization of a synthetic phosphatidylglycerol membrane but PZQ has only little effect. Electronmicroscopic pictures reveal that fluoxetine does not induce fusion of synthetic phospholipid vesicles, which is in agreement with the findings that many amphiphilic cationic drugs inhibit fusion processes (Poste & Allison 1973) . In the presence of PZQ, however, we observe aggregation and fusion of these vesicles.
Schistosomu tnansoni are flaccidly paralysed when incubated with these cationic drugs; in the presence of PZQ, however, they showed spastic paralysis. This difference can be explained by the different effects of the drugs on membrane-associated Ca'+ ( Fig. 3) : amphiphilic cationic drugs reduce membrane bound Ca'+. which leads to flaccid paralysis; PZQ, on the other hand, enhances Ca'+ permeability by membrane perturbation. The resulting influx of Ca'+ causes spastic paralysis of the parasites. When the PZQinduced damage of the parasite's tegument is sufficiently severe, the resulting Ca'+ influx will disrupt various regulation processes triggered by Ca'+ and this then leads to the death of the parasite. The first non-antimonial drug against schistosomiasis was introduced into clinical practice after World War I1 under the generic name, lucanthone (Fig. I) . It was later discovered that lucanthone is metabolically converted by the host into the hydroxymethyl analogue. hycanthone (HC. Fig. I) , which is the therapeutically active substance (Archer, 1985) . In the late 1960s a group of tetrahydroquinolines was synthesized at Pfizer Ltd. (Richards & Foster, 1969) and the compound with the most pronounced antischistosomal properties was designated as UK-3883 (Fig. I ).
Abhrcviations used: HC. hycanthone; OXA. oxamniquinc: HNMC.
hycanthonc-N-methylcarbarnate.
Oxidation of the methyl group of UK-3883 (Kaye & Woolhouse, 1972) gave oxamniquine (OXA, Fig. I ), a compound which is still one of the drugs of choice in the therapy of Schistosoma mansoni infections. Some structural similarities exist between compounds of the HC and OXA series, as outlined in Fig. I . We suggest here the possibility that the two drugs may also have a similar mechanism of action.
Hycanthone
While lucanthone, as expected, has no schistosomicidal activity in vifro, HC is totally effective, thus showing that no host metabolism is required for HC activation (Cioli & Knopf, 1980) . The peculiar time course of HC activity is worth consideration, since a very short contact in v i m (about I5 min) between the schistosomes and the compound leads to a typically delayed worm death (a couple of weeks later). HC is more effective against male schistosomes. I t is largely inactive against immature schistosomes and totally inactive against S. japonicum (Yarinsky ct (11.. 1972) . In addition,
